ATE234077T1 - Orale pharmazeutische zusammensetzung enthaltend einen wirkstoff mit antimykotischer wirkung und verfahren zu ihrer herstellung - Google Patents

Orale pharmazeutische zusammensetzung enthaltend einen wirkstoff mit antimykotischer wirkung und verfahren zu ihrer herstellung

Info

Publication number
ATE234077T1
ATE234077T1 AT99931261T AT99931261T ATE234077T1 AT E234077 T1 ATE234077 T1 AT E234077T1 AT 99931261 T AT99931261 T AT 99931261T AT 99931261 T AT99931261 T AT 99931261T AT E234077 T1 ATE234077 T1 AT E234077T1
Authority
AT
Austria
Prior art keywords
production
coat
pharmaceutical composition
composition containing
active substance
Prior art date
Application number
AT99931261T
Other languages
English (en)
Inventor
Darder Carlos Picornell
Original Assignee
Liconsa Liberacion Controlada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE234077(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa Liberacion Controlada filed Critical Liconsa Liberacion Controlada
Application granted granted Critical
Publication of ATE234077T1 publication Critical patent/ATE234077T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT99931261T 1998-07-21 1999-07-20 Orale pharmazeutische zusammensetzung enthaltend einen wirkstoff mit antimykotischer wirkung und verfahren zu ihrer herstellung ATE234077T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (1)

Publication Number Publication Date
ATE234077T1 true ATE234077T1 (de) 2003-03-15

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99931261T ATE234077T1 (de) 1998-07-21 1999-07-20 Orale pharmazeutische zusammensetzung enthaltend einen wirkstoff mit antimykotischer wirkung und verfahren zu ihrer herstellung

Country Status (31)

Country Link
US (1) US6737082B1 (de)
EP (1) EP1103252B1 (de)
JP (1) JP4190732B2 (de)
KR (1) KR100572135B1 (de)
AT (1) ATE234077T1 (de)
AU (1) AU750730B2 (de)
BG (1) BG65187B1 (de)
BR (1) BR9912300A (de)
CA (1) CA2337509C (de)
CZ (1) CZ291938B6 (de)
DE (1) DE69905905T2 (de)
DK (1) DK1103252T3 (de)
EE (1) EE04415B1 (de)
ES (2) ES2157731B1 (de)
HK (1) HK1037531A1 (de)
HR (1) HRP20010128B1 (de)
HU (1) HU228895B1 (de)
IL (1) IL140910A (de)
ME (1) MEP26708A (de)
MX (1) MXPA01000681A (de)
NO (1) NO320054B1 (de)
NZ (1) NZ509886A (de)
PL (1) PL194740B1 (de)
PT (1) PT1103252E (de)
RS (1) RS50063B (de)
RU (1) RU2209628C2 (de)
SK (1) SK283279B6 (de)
TR (1) TR200100177T2 (de)
UA (1) UA64009C2 (de)
WO (1) WO2000004881A1 (de)
ZA (1) ZA200101293B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2243981C (en) * 1996-01-31 2005-09-06 South Alabama Medical Science Foundation Food and vitamin preparations containing the natural isomer of reduced folates
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GEP20053427B (en) 1999-12-23 2005-01-25 Pfizer Prod Inc Pharmaceutical Compositions Providing Enhanced Drug Concentrations
FR2842736B1 (fr) * 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
ES2283724T5 (es) * 2003-01-14 2013-04-09 Acino Pharma Ag Composición de itraconazol dispersada en un polímero hidrófilo con biodisponibilidad potenciada
DE60312636T3 (de) * 2003-01-14 2014-12-24 Acino Pharma Ag Bioaequivalente Zusammensetzung in der Form einer festen Dispersion enthaltend Itraconazol und ein hydrophiles Polymer
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
ES2667668T3 (es) * 2003-07-17 2018-05-14 Janssen Sciences Ireland Uc Procedimiento para preparar partículas que contienen un antiviral
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
EP1919480B1 (de) 2005-08-22 2013-01-16 The Johns Hopkins University Hedgehog-weg-antagonisten zur behandlung von krankheiten
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
EP2542222A2 (de) * 2010-03-05 2013-01-09 Basf Se Schmelzüberzogene arzneiformen
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
AU2016268489A1 (en) * 2015-05-25 2017-12-14 Sun Pharmaceutical Industries Limited Once daily oral pharmaceutical composition of isotretinoin
WO2018031935A1 (en) 2016-08-11 2018-02-15 Adamis Pharmaceuticals Corporation Drug compositions
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
EP3720844A4 (de) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation Arzneimittelzusammensetzungen
CN112313289A (zh) * 2018-04-27 2021-02-02 凸版印刷株式会社 缓释性复合颗粒、缓释性复合颗粒的制造方法、干燥粉体、以及壁纸
WO2023118082A1 (en) * 2021-12-22 2023-06-29 Palau Pharma, S.L.U. Multiparticulate albaconazole composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
EP0904060B1 (de) * 1996-05-20 2003-12-10 Janssen Pharmaceutica N.V. Fungizide mittel mit verbesserter bioverfügbarkeit
EP0914127B1 (de) * 1996-05-24 2002-02-27 Schering Corporation Fungizide zusammensetzung mit erhörter bioverfügbarkeit
WO1998000116A1 (en) * 1996-06-28 1998-01-08 Schering Corporation Oral composition comprising a triazole antifungal compound
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
SI0969821T1 (en) 1997-03-26 2003-10-31 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer

Also Published As

Publication number Publication date
DE69905905D1 (de) 2003-04-17
ES2157731A1 (es) 2001-08-16
DE69905905T2 (de) 2004-03-04
NO20010289L (no) 2001-03-07
CA2337509C (en) 2005-12-27
PL194740B1 (pl) 2007-06-29
CZ2001175A3 (en) 2001-05-16
SK862001A3 (en) 2001-08-06
CZ291938B6 (cs) 2003-06-18
HK1037531A1 (en) 2002-02-15
CA2337509A1 (en) 2000-02-03
ZA200101293B (en) 2001-08-21
TR200100177T2 (tr) 2001-07-23
EP1103252B1 (de) 2003-03-12
BG105282A (en) 2001-11-30
HUP0103708A3 (en) 2002-07-29
EE200100041A (et) 2002-06-17
MXPA01000681A (es) 2002-04-24
IL140910A0 (en) 2002-02-10
KR100572135B1 (ko) 2006-04-19
YU3901A (sh) 2003-08-29
NZ509886A (en) 2002-09-27
AU4782199A (en) 2000-02-14
IL140910A (en) 2004-03-28
EE04415B1 (et) 2005-02-15
BR9912300A (pt) 2001-04-17
HUP0103708A2 (hu) 2002-02-28
JP4190732B2 (ja) 2008-12-03
RS50063B (sr) 2009-01-22
ES2157731B1 (es) 2002-05-01
PT1103252E (pt) 2003-07-31
PL345625A1 (en) 2002-01-02
WO2000004881A1 (es) 2000-02-03
JP2002521323A (ja) 2002-07-16
BG65187B1 (bg) 2007-06-29
RU2209628C2 (ru) 2003-08-10
EP1103252A1 (de) 2001-05-30
HU228895B1 (en) 2013-06-28
UA64009C2 (en) 2004-02-16
AU750730B2 (en) 2002-07-25
NO20010289D0 (no) 2001-01-17
HRP20010128B1 (en) 2003-12-31
DK1103252T3 (da) 2003-07-14
ES2194480T3 (es) 2003-11-16
MEP26708A (en) 2010-06-10
US6737082B1 (en) 2004-05-18
KR20010070990A (ko) 2001-07-28
HRP20010128A2 (en) 2002-12-31
NO320054B1 (no) 2005-10-17
SK283279B6 (sk) 2003-05-02

Similar Documents

Publication Publication Date Title
ATE234077T1 (de) Orale pharmazeutische zusammensetzung enthaltend einen wirkstoff mit antimykotischer wirkung und verfahren zu ihrer herstellung
DE69431807T2 (de) Teilchenförmige synthetische Träger sowie Verfahren zu deren Herstellung
CA2322875A1 (en) A coated chewing gum, a method for preparation thereof and the use of one or more active substance(s) in solid form
EP0351760A3 (de) Futterzusatzmittel für Wiederkäuer
ATE399601T1 (de) Antimikrobielle verpackungsmaterialien und verfahren zur herstellung derselben
NO178136C (no) Framgangsmåte for framstilling av et preparat for styrt frigjöring av en farmasöytisk aktiv substans
ATE53490T1 (de) Arzneipraeparate mit geregelter wirkstoffabgabe.
WO2004071341A3 (en) Disposable absorbent article comprising a durable hydrophilic core wrap
DE3779189D1 (de) Arzneimittel mit komplexierender wirkung auf gallensaeuren, die cholestyramin als wirkstoff enthalten, sowie verfahren zu deren herstellung.
DE59806578D1 (de) Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen
NO20000284D0 (no) Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen
DE60133028D1 (de) Mikrogranulat auf wirkstoffbasis und verfahren zu seiner herstellung
DE68900029D1 (de) Pyrazolderivate, verfahren zu ihrer herstellung und diese derivate als aktive komponente enthaltende insektizide, mitizide und fungizide zusammensetzungen.
ATE531360T1 (de) Mikrokügelchen mit verzögerter freisetzung und verfahren zu ihrer herstellung
AU2117588A (en) Process for microencapsulation, uses of polymers prepared by said process, and compositions containing polymers prepared by said process
ATE265804T1 (de) Überzogene pestizide mittel, verfahren zu deren herstellung sowie diese enthaltende mittel
ATE9957T1 (de) Verfahren zur herstellung eines umhuellten acetylsalicylsaeurepraeparates.
DE50009701D1 (de) Pulverförmige Wirkstoffzusammensetzung, Verfahren zu deren Herstellung und Verwendung derselben
ES8800838A1 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1103252

Country of ref document: EP

EEFA Change of the company name